Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foscarnet Salvage Therapy for CMV Retinitis in AIDS (ACTG 093)
NCT00000691Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of foscarnet sodium in cytomegalovirus retinitis, sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
foscarnet sodium
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT00000691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000691.